CN Patent

CN101402631A — 氨基喹唑啉二马来酸盐、其制备方法及其用途

Assigned to Boehringer Ingelheim International GmbH · Expires 2009-04-08 · 17y expired

What this patent protects

本发明涉及氨基喹唑啉二马来酸盐、其制备方法及其用途。具体地，本发明涉及4－[(3－氯－4－氟苯基)氨基]－6－{[4－(N，N－二甲基氨基)－1－氧代－2－丁烯－1－基]氨基}－7－((S)－四氢呋喃－3－基氧)－喹唑啉二马来酸盐、其制备方法，包含该化合物的药物组合物及其在用于制备药物中的用途。

USPTO Abstract

本发明涉及氨基喹唑啉二马来酸盐、其制备方法及其用途。具体地，本发明涉及4－[(3－氯－4－氟苯基)氨基]－6－{[4－(N，N－二甲基氨基)－1－氧代－2－丁烯－1－基]氨基}－7－((S)－四氢呋喃－3－基氧)－喹唑啉二马来酸盐、其制备方法，包含该化合物的药物组合物及其在用于制备药物中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN101402631A
Jurisdiction
CN
Classification
—
Expires
2009-04-08
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.